The ability of the Hidrosmin is to suppress the vasculature of the aneurysm, immediately inhibit the vascular formation of the aneurysm. As a result, the growth of vascular endothelial cells (the main cell type in the vascular wall), the migration of lumen formation, etc. have become more realistic. In particular, the secretion of the base can be determined by certain small signal channels or molecular points during the angiogenesis process, which inhibits the angiogenesis process from progressing.
1. Suppression of the growth length of the aneurysm: The growth length of the aneurysm is highly dependent on the formation of new blood vessels, so the growth of the aneurysm is suppressed as long as the growth of the aneurysm is suppressed.
2. Provide high treatment effect: During anti-cancer treatment, the use of the base Okushi Akira and other anti-cancer substances can be combined, and the high treatment effect can be achieved. Suppressing the flow of blood vessels, making the base Okushi clearer and making it less resistant to physical damage, making it easier for physical attacks to occur.
The main use for treatment is gastrointestinal and pelvic aneurysms, as well as gastrointestinal and pelvic cancers. In the current treatment of the aneurysm, the anti-angiogenic effect of the anti-angiogenic effect has been shown to be important, the survival rate of the aneurysm has increased, and the survival rate of the patient has increased.